FINWIRES · TerminalLIVE
FINWIRES

NEC Capital Solutions Issues 24 Billion Yen in Two Unsecured Bond Series

By

NEC Capital Solutions (TYO:8793) plans to issue its 32nd and 33rd unsecured bond series, each totalling 12 billion yen, according to a Tokyo bourse filing on Friday.

The 32nd bonds carry an interest rate of 2.086% with a maturity date of May 28, 2029, while the 33rd bonds bear a 2.567% rate and mature on May 28, 2031.

Both series are unsecured, have a face value of 100 million yen per bond, and will be issued at par with redemption also at par.

The bonds received credit ratings of A from Japan Credit Rating Agency and A- from Rating & Investment Information, with payment scheduled for May 28.

Related Articles

Asia

Market Chatter: Indonesia and Malaysia Allow Ownership Change of Oil, Gas Assets to Petronas-Eni JV

The governments of Indonesia and Malaysia gave a go-ahead for the transfer of certain oil and gas block ownership from Malaysia's Petronas and Italy's Eni to their JV firm SEARAH, Reuters reported Thursday citing a Petronas executive.The approval is reportedly for the transfer of the assets' production-sharing contracts to the joint venture, the head of Petronas in Indonesia ​told Reuters at an Indonesia Petroleum Association conference.The parties had, in November, agreed to form a JV company to manage 19 assets, of which 14 are in Indonesia and five fall in Malaysia.The deal is expected to be completed by July 1, the newswire said, citing the executive.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^JKSE$^KLSE
Asia

Asahi Group Sees Flat Interim Dividend for 2026

Asahi Group's (TYO:2502) expects to pay an interim dividend forecast of 26 yen per share for 2026, unchanged from last year, according to a Friday filing with the Tokyo bourse.Due to ongoing delays in finalizing 2025 consolidated results caused by a cyberattack in September 2025, the company has opted to keep the interim dividend at the prior year's level.The forecast for the year-end dividend will be decided once the company's consolidated financial position and full-year results are finalized.

$TYO:2502
Asia

Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug

Zhuhai Rundu Pharmaceutical (SHE:002923) obtained drug registration from China's medical products regulator for 75- and 100-milligram dosages of diclofenac sodium sustained-release tablets.The drug is indicated for chronic arthritis, soft tissue rheumatic pain and acute mild to moderate pain, according to a Friday fling with the Shenzhen bourse.Shares of the pharmaceutical company closed 1% higher Friday.

$SHE:002923